Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
MSAC was delisted on the 17th of February, 2023.
55 hedge funds and large institutions have $103M invested in Medicus Sciences Acquisition Corp. Class A Ordinary Share in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 5 closing their positions.
200% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 5
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
33% more capital invested
Capital invested by funds: $77.5M → $103M (+$25.5M)
20% more funds holding
Funds holding: 46 → 55 (+9)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$22.6M |
| 2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$2.73M |
| 3 |
CC
Centiva Capital
New York
|
+$2.43M |
| 4 |
D.E. Shaw & Co
New York
|
+$2.24M |
| 5 |
SCM
Saba Capital Management
New York
|
+$2.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$7.25M |
| 2 |
KC
Kepos Capital
New York
|
-$3.9M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$962K |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$488K |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$237K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AA
51
Ancora Advisors
Cleveland,
Ohio
| $35K | – | – | – |
|
|
CCM
52
Condor Capital Management
Martinsville,
New Jersey
| $27K | – | – | – |
|
53
UBS Group
Zurich,
Switzerland
| $25K | +$25.2K | +2,590 | New |
|
|
TRCT
54
Tower Research Capital (TRC)
New York
| $11K | +$10.9K | +1,117 | New |
|
55
JP Morgan Chase
New York
| $1K | +$972 | +100 | New |
|
|
HM
56
HealthCor Management
New York
| – | -$7.25M | -744,000 | Closed |
|
|
KC
57
Kepos Capital
New York
| – | -$3.9M | -400,000 | Closed |
|
|
AA
58
AQR Arbitrage
Greenwich,
Connecticut
| – | -$962K | -98,630 | Closed |
|
|
PCM
59
Pentwater Capital Management
Naples,
Florida
| – | -$488K | -50,000 | Closed |
|
|
MP
60
Mangrove Partners
Greenwich,
Connecticut
| – | -$237K | -24,260 | Closed |
|
MSAC Hedge Fund Activity: Q4 2021 in Review
55 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) for Q4 2021, worth a combined $103M — up 33% from $77.5M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new MSAC positions and 5 closed out — a net gain of 10 holders — while 5 added to existing stakes and 7 trimmed.
The largest buyer was Sio Capital Management, opening a new position worth an estimated $22.6M. The largest seller was HealthCor Management, exiting entirely with an estimated $7.25M sold.
- 55 institutional investors held Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) as of Q4 2021, up from 46 in Q3 2021.
- Funds reported $103M of Medicus Sciences Acquisition Corp. Class A Ordinary Share stock for Q4 2021, up 33% quarter-over-quarter.
- 15 funds opened new Medicus Sciences Acquisition Corp. Class A Ordinary Share positions in Q4 2021 and 5 closed out, a net change of +10 holders.
- The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share buyer in Q4 2021 was Sio Capital Management, an estimated $22.6M added.
- The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share seller in Q4 2021 was HealthCor Management, an estimated $7.25M sold.
Based on aggregated 13F filings for Q4 2021.